Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

Quick Read Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.

More than a decade into their partnership, Masimo and GE HealthCare are still finding new ways to combine their respective patient monitoring technologies. In the latest expansion of their ...

Danaher Corporation, a global science and technology company, has entered into a definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider of pulse oximetry and ...

Masimo MASI recently entered into a definitive agreement, pursuant to which it will be acquired by the global conglomerate, ...

The latest legal dispute between Apple and pulse oximetry company Masimo today ended in a mistrial, reports Bloomberg. The jury overseeing the case was not able to come to a final decision in its ...

Masimo CEO Joe Kiani took advantage of an interview to slam Apple's implementation of pulse oximetry in the Apple Watch, and confirm that there have not been recent settlement talks. Masimo CEO Joe ...